Johnson & Johnson reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 85,159 million compared to USD 79,990 million a year ago. Net income was USD 35,153 million compared to USD 17,941 million a year ago.

Diluted earnings per share from continuing operations was USD 5.2 compared to USD 6.14 a year ago.